$RELY
Remitly Global, Inc.

2021 Q4 Form 10-Q Financial Statement

#000178217021000011 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $135.3M $121.2M $71.79M
YoY Change 69.03% 68.89%
Cost Of Revenue $56.43M $47.56M $28.00M
YoY Change 55.89% 69.86%
Gross Profit $78.82M $73.68M $43.70M
YoY Change 79.55% 68.61%
Gross Profit Margin 58.28% 60.77% 60.87%
Selling, General & Admin $74.87M $66.91M $62.16M
YoY Change -1.9% 7.64%
% of Gross Profit 94.98% 90.81% 142.24%
Research & Development $19.13M $18.12M $10.38M
YoY Change 69.27% 74.6%
% of Gross Profit 24.27% 24.6% 23.75%
Depreciation & Amortization $1.366M $1.319M $1.002M
YoY Change 13.74% 31.64%
% of Gross Profit 1.73% 1.79% 2.29%
Operating Expenses $95.36M $18.12M $10.38M
YoY Change 7.32% 74.6%
Operating Profit -$16.54M -$12.67M -$1.753M
YoY Change -63.21% 622.59%
Interest Expense -$160.0K $512.0K $247.0K
YoY Change 128.57% 107.29%
% of Operating Profit
Other Income/Expense, Net $81.00K $396.0K -$241.0K
YoY Change -81.38% -264.32%
Pretax Income -$16.62M -$12.70M -$2.234M
YoY Change 96.04% 468.53%
Income Tax -$42.00K $261.0K $195.0K
% Of Pretax Income
Net Earnings -$16.58M -$12.96M -$2.429M
YoY Change 84.08% 433.64%
Net Earnings / Revenue -12.26% -10.69% -3.38%
Basic Earnings Per Share -$0.41 -$0.11
Diluted Earnings Per Share -$100.1K -$0.41 -$0.11
COMMON SHARES
Basic Shares Outstanding 164.1M shares 31.64M shares 21.87M shares
Diluted Shares Outstanding 31.64M shares 21.87M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $522.9M $552.1M
YoY Change
Cash & Equivalents $403.3M $443.3M $149.9M
Short-Term Investments
Other Short-Term Assets $17.45M $15.99M
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $607.6M $647.3M
YoY Change 75.93%
LONG-TERM ASSETS
Property, Plant & Equipment $9.249M $9.225M
YoY Change -4.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.510M $1.972M
YoY Change 252.06%
Total Long-Term Assets $18.11M $17.55M
YoY Change 2.57%
TOTAL ASSETS
Total Short-Term Assets $607.6M $647.3M
Total Long-Term Assets $18.11M $17.55M
Total Assets $625.7M $664.9M
YoY Change 72.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.210M $6.869M
YoY Change -71.57%
Accrued Expenses $66.68M $57.70M
YoY Change 67.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $141.6M $172.7M
YoY Change -22.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $813.0K $901.0K
YoY Change -1.69%
Total Long-Term Liabilities $813.0K $901.0K
YoY Change -1.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $141.6M $172.7M
Total Long-Term Liabilities $813.0K $901.0K
Total Liabilities $145.3M $177.2M
YoY Change -22.12%
SHAREHOLDERS EQUITY
Retained Earnings -$259.4M -$242.9M
YoY Change 17.56%
Common Stock $16.00K $16.00K
YoY Change 700.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $480.3M $487.7M -$204.4M
YoY Change
Total Liabilities & Shareholders Equity $625.7M $664.9M
YoY Change 72.36%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$16.58M -$12.96M -$2.429M
YoY Change 84.08% 433.64%
Depreciation, Depletion And Amortization $1.366M $1.319M $1.002M
YoY Change 13.74% 31.64%
Cash From Operating Activities -$37.82M -$40.85M -$23.59M
YoY Change -12.12% 73.17%
INVESTING ACTIVITIES
Capital Expenditures -$1.246M -$1.036M -$1.044M
YoY Change 30.61% -0.77%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.246M -$1.036M -$1.044M
YoY Change 30.61% -0.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.462M 312.3M 67.83M
YoY Change -101.82% 360.43%
NET CHANGE
Cash From Operating Activities -37.82M -40.85M -23.59M
Cash From Investing Activities -1.246M -1.036M -1.044M
Cash From Financing Activities -1.462M 312.3M 67.83M
Net Change In Cash -40.52M 270.4M 43.20M
YoY Change -211.39% 526.02%
FREE CASH FLOW
Cash From Operating Activities -$37.82M -$40.85M -$23.59M
Capital Expenditures -$1.246M -$1.036M -$1.044M
Free Cash Flow -$36.57M -$39.82M -$22.55M
YoY Change -13.09% 76.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001782170
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
021-344104
dei Entity Registrant Name
EntityRegistrantName
Remitly Global, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2301143
dei Entity Address Address Line1
EntityAddressAddressLine1
1111 Third Avenue,
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2100
dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle,
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98101
dei City Area Code
CityAreaCode
(888)
dei Local Phone Number
LocalPhoneNumber
736-4859
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
RELY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
164106480 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
443313000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
186694000 USD
CY2021Q3 rely Disbursement Prefunding
DisbursementPrefunding
108770000 USD
CY2020Q4 rely Disbursement Prefunding
DisbursementPrefunding
101558000 USD
CY2021Q3 us-gaap Settlement Assets Current
SettlementAssetsCurrent
79243000 USD
CY2020Q4 us-gaap Settlement Assets Current
SettlementAssetsCurrent
50729000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15992000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6350000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
647318000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
345331000 USD
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
302000 USD
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1381000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9225000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9675000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6052000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5605000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1972000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
997000 USD
CY2021Q3 us-gaap Assets
Assets
664869000 USD
CY2020Q4 us-gaap Assets
Assets
362989000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6869000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4256000 USD
CY2021Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
80000000 USD
CY2021Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
104683000 USD
CY2020Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
54819000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57699000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39742000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3411000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2959000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
172662000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
181776000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3623000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4008000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
901000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
827000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
177186000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
186611000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
50000000 shares
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
132674735 shares
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
127082605 shares
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
127082605 shares
CY2021Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0 USD
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
399815000 USD
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
387707000 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
725000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
163765500 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
163765500 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24289906 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24289906 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
16000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
730253000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8766000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
282000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
591000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-242868000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-220688000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
487683000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-211329000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
664869000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
362989000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121244000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71790000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
323350000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
176939000 USD
CY2021Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
30365000 USD
CY2020Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
18816000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
82639000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
50923000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18123000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10380000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44965000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29439000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24539000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7667000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47429000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22008000 USD
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1319000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1002000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3890000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2859000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
133911000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
73543000 USD
us-gaap Costs And Expenses
CostsAndExpenses
346533000 USD
us-gaap Costs And Expenses
CostsAndExpenses
197280000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12667000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1753000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-23183000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-20341000 USD
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
82000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
92000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
181000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
512000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
247000 USD
us-gaap Interest Expense
InterestExpense
1048000 USD
us-gaap Interest Expense
InterestExpense
1027000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
396000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-241000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3044000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1737000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12701000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2234000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21095000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22924000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
261000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1085000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
635000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12962000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2429000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22180000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23559000 USD
CY2021Q3 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
0 USD
CY2020Q3 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
0 USD
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
0 USD
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
0 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12962000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-12962000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2429000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2429000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-22180000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22180000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-23559000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23559000 USD
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Net Income Loss
NetIncomeLoss
-23559000 USD
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.11
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31641400 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31641400 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21868865 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21868865 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26055903 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26055903 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21186012 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21186012 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12962000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2429000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22180000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-293000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2341000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4861000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
219000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-309000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
156000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13255000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2210000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22489000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23403000 USD
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
127410631 shares
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
390687000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-212135000 USD
CY2021Q3 rely Adjustments To Additional Paid In Capital Non Recourse Promissory Note
AdjustmentsToAdditionalPaidInCapitalNonRecoursePromissoryNote
3060000 USD
CY2021Q3 rely Temporary Equity Shares Redeemed Upon Conversion Shares
TemporaryEquitySharesRedeemedUponConversionShares
127410631 shares
CY2021Q3 rely Temporary Equity Shares Redeemed Upon Conversion Amount
TemporaryEquitySharesRedeemedUponConversionAmount
390687000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
390687000 USD
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
305191000 USD
CY2021Q3 rely Stock Issued During Period Value Donations
StockIssuedDuringPeriodValueDonations
6933000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-293000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12962000 USD
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
487683000 USD
CY2020Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
117788521 shares
CY2020Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
302873000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-204540000 USD
CY2020Q3 rely Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
9294084 shares
CY2020Q3 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
84834000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
975000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1329000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
219000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2429000 USD
CY2020Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
127082605 shares
CY2020Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
387707000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-204446000 USD
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
127082605 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
387707000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-211329000 USD
rely Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
328026 shares
us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
2980000 USD
rely Adjustments To Additional Paid In Capital Non Recourse Promissory Note
AdjustmentsToAdditionalPaidInCapitalNonRecoursePromissoryNote
3060000 USD
rely Temporary Equity Shares Redeemed Upon Conversion Shares
TemporaryEquitySharesRedeemedUponConversionShares
127410631 shares
rely Temporary Equity Shares Redeemed Upon Conversion Amount
TemporaryEquitySharesRedeemedUponConversionAmount
390687000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
390687000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
305191000 USD
rely Stock Issued During Period Value Donations
StockIssuedDuringPeriodValueDonations
6933000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6375000 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
169000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9086000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-309000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-204446000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22180000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23559000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22180000 USD
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
487683000 USD
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
117788521 shares
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
302873000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-186796000 USD
rely Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
167000 USD
rely Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
9294084 shares
us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
84834000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1901000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3852000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
156000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23559000 USD
CY2020Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
127082605 shares
CY2020Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
387707000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3890000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2859000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8965000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3852000 USD
us-gaap Noncash Contribution Expense
NoncashContributionExpense
6933000 USD
us-gaap Noncash Contribution Expense
NoncashContributionExpense
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-360000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-27000 USD
rely Increase Decrease In Disbursement Prefunding
IncreaseDecreaseInDisbursementPrefunding
7212000 USD
rely Increase Decrease In Disbursement Prefunding
IncreaseDecreaseInDisbursementPrefunding
30345000 USD
rely Increase Decrease In Settlement Assets
IncreaseDecreaseInSettlementAssets
29072000 USD
rely Increase Decrease In Settlement Assets
IncreaseDecreaseInSettlementAssets
13465000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9491000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4952000 USD
rely Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-2023000 USD
rely Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1803000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1229000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1840000 USD
rely Increase Decrease In Settlement Liabilities
IncreaseDecreaseInSettlementLiabilities
50284000 USD
rely Increase Decrease In Settlement Liabilities
IncreaseDecreaseInSettlementLiabilities
-28916000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
16013000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
21595000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2317000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1915000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19425000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-71176000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1347000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1825000 USD
us-gaap Payments For Software
PaymentsForSoftware
1941000 USD
us-gaap Payments For Software
PaymentsForSoftware
1591000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3288000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3416000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
307094000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3060000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
2980000 USD
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
84855000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7519000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1995000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
988000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-80000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-45000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
239665000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41850000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-262000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
338000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
255540000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32404000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188075000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
4300000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
183520000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
443615000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151116000 USD
us-gaap Interest Paid Net
InterestPaidNet
936000 USD
us-gaap Interest Paid Net
InterestPaidNet
998000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
303000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
334000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2532000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1523000 USD
rely Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
263000 USD
rely Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
69000 USD
rely Financing And Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
FinancingAndStockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
2287000 USD
rely Financing And Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
FinancingAndStockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
390687000 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
443313000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149881000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
302000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1235000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
443615000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151116000 USD
CY2021Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
305200000 USD
CY2021Q3 rely Sale Of Stock Stock Issuance Costs
SaleOfStockStockIssuanceCosts
20800000 USD
CY2021Q3 rely Temporary Equity Shares Redeemed Upon Conversion Shares
TemporaryEquitySharesRedeemedUponConversionShares
127410631 shares
CY2021Q3 rely Temporary Equity Shares Redeemed Conversion Ratio
TemporaryEquitySharesRedeemedConversionRatio
1
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. These estimates and assumptions include, but are not limited to, revenue recognition including the treatment of sales incentive programs, reserves for transaction losses, stock-based </span></div>compensation expense including the estimated fair value per share of common stock, the carrying value of operating lease right-of-use assets, the recoverability of deferred tax assets, and capitalization of software development costs. The Company bases its estimates on historical experience and on assumptions that management considers reasonable. Actual results could differ from these estimates and assumptions, and these differences could be material to the condensed consolidated financial statements.
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, disbursement prefunding, restricted cash, and customer funds receivable. The Company maintains cash and cash equivalents and restricted cash balances that may exceed the insured limits by the Federal Deposit Insurance Corporation. In addition, the Company funds its international operations using accounts with institutions in the major countries where its subsidiaries operate. The Company also prefunds amounts which are held by its disbursement partners, which typically include India, Philippines and Mexico. The Company has not experienced any significant losses on its deposits of cash and cash equivalents, disbursement prefunding, restricted cash or customer funds receivable in the nine months ended September 30, 2021 and 2020.</span></div>
CY2021Q3 us-gaap Advertising Expense
AdvertisingExpense
25600000 USD
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
15900000 USD
us-gaap Advertising Expense
AdvertisingExpense
70100000 USD
us-gaap Advertising Expense
AdvertisingExpense
42500000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1126000 USD
CY2021Q3 rely Deferred Offering Costs Payable
DeferredOfferingCostsPayable
1900000 USD
CY2020Q4 rely Deferred Offering Costs Payable
DeferredOfferingCostsPayable
0 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
274000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1105000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
137000 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1269000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1010000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1269000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1010000 USD
CY2021Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
143000 USD
CY2020Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
736000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
164000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
873000 USD
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20975000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17591000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11750000 USD
rely Hosting Arrangement Service Contract Implementation Cost Capitalized Additions
HostingArrangementServiceContractImplementationCostCapitalizedAdditions
2000000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7916000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9225000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9675000 USD
CY2021Q3 us-gaap Depreciation
Depreciation
1300000 USD
us-gaap Depreciation
Depreciation
3900000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
1000000 USD
us-gaap Depreciation
Depreciation
2900000 USD
us-gaap Hosting Arrangement Service Contract Implementation Cost Impairment
HostingArrangementServiceContractImplementationCostImpairment
0 USD
us-gaap Hosting Arrangement Service Contract Implementation Cost Impairment
HostingArrangementServiceContractImplementationCostImpairment
0 USD
CY2021Q3 us-gaap Hosting Arrangement Service Contract Implementation Cost Impairment
HostingArrangementServiceContractImplementationCostImpairment
0 USD
CY2020Q3 us-gaap Hosting Arrangement Service Contract Implementation Cost Impairment
HostingArrangementServiceContractImplementationCostImpairment
0 USD
CY2021Q3 rely Hosting Arrangement Service Contract Implementation Cost Capitalized Additions
HostingArrangementServiceContractImplementationCostCapitalizedAdditions
500000 USD
CY2020Q3 rely Hosting Arrangement Service Contract Implementation Cost Capitalized Additions
HostingArrangementServiceContractImplementationCostCapitalizedAdditions
600000 USD
CY2021Q3 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
600000 USD
CY2020Q3 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
400000 USD
rely Hosting Arrangement Service Contract Implementation Cost Capitalized Additions
HostingArrangementServiceContractImplementationCostCapitalizedAdditions
1600000 USD
us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
1800000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-12962000 USD
us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
1100000 USD
CY2021Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
19200000 USD
CY2020Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
9400000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12962000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2429000 USD
us-gaap Net Income Loss
NetIncomeLoss
-22180000 USD
us-gaap Net Income Loss
NetIncomeLoss
-23559000 USD
CY2021Q3 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
0 USD
CY2020Q3 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
0 USD
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
0 USD
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
0 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26055903 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21186012 shares
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12962000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2429000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2429000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-22180000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-22180000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23559000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-23559000 USD
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31641400 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31641400 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21868865 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21868865 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26055903 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21186012 shares
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.88
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M25D
CY2021Q3 us-gaap Noncash Contribution Expense
NoncashContributionExpense
6900000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.11
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25917130 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
149148875 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
725000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 rely Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2021Q3 rely Temporary Equity Shares Redeemed Upon Conversion Amount
TemporaryEquitySharesRedeemedUponConversionAmount
390700000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21034424 shares
CY2021Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
50000000 shares
CY2021Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P10Y
CY2021Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
256250 shares
CY2021Q3 rely Stock Issued During Period Shares Warrants
StockIssuedDuringPeriodSharesWarrants
254014 shares
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
256250 shares
CY2021Q3 rely Temporary Equity Shares Redeemed Upon Conversion Shares
TemporaryEquitySharesRedeemedUponConversionShares
127410631 shares
CY2021Q3 rely Temporary Equity Shares Redeemed Conversion Ratio
TemporaryEquitySharesRedeemedConversionRatio
1
CY2020Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
132674735 shares
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
127082605 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
127082605 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
387707000 USD
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
399815000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
64604000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8219753 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.26
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4021834 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
66970000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1171270 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.24
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
24061073 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.68
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M28D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
785826000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
9397761 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.63
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y5M19D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
320288000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
24561046 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y10M28D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
802853000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.31
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.28
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.22
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.00
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2100000 USD
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1400000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
5400000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3800000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4740000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1329000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8965000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3852000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
67600000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.028
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.021
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.087
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.051
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
176939000 USD
rely Defined Contribution Plan Maximum Annual Employer Contribution Per Employee Amount
DefinedContributionPlanMaximumAnnualEmployerContributionPerEmployeeAmount
1000 USD
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000 USD
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000 USD
CY2021Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 USD
CY2020Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 USD
CY2021Q3 rely Trade Settlement Liability
TradeSettlementLiability
20618000 USD
CY2020Q4 rely Trade Settlement Liability
TradeSettlementLiability
16700000 USD
CY2021Q3 rely Accrued Transaction Expense
AccruedTransactionExpense
10754000 USD
CY2020Q4 rely Accrued Transaction Expense
AccruedTransactionExpense
6399000 USD
CY2021Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
7659000 USD
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
4883000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5975000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1960000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11186000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6550000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57699000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39742000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
121244000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71790000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
323350000 USD

Files In Submission

Name View Source Status
0001782170-21-000011-index-headers.html Edgar Link pending
0001782170-21-000011-index.html Edgar Link pending
0001782170-21-000011.txt Edgar Link pending
0001782170-21-000011-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
exhibit33-remitlyglobalxpu.htm Edgar Link pending
exhibit34-remitlyglobalxpu.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
rely-20210930.htm Edgar Link pending
rely-20210930.xsd Edgar Link pending
rely-20210930_cal.xml Edgar Link unprocessable
rely-20210930_def.xml Edgar Link unprocessable
rely-20210930_htm.xml Edgar Link completed
rely-20210930_lab.xml Edgar Link unprocessable
rely-20210930_pre.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending